Insulin Aspart Patent Expiration

Insulin Aspart was first introduced by Novo Nordisk Inc in its drug Fiasp on Sep 29, 2017. Other drugs containing Insulin Aspart are Fiasp Penfill, Fiasp Flextouch.


Insulin Aspart Patents

Given below is the list of patents protecting Insulin Aspart, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Fiasp Flextouch US9132239 Dial-down mechanism for wind-up pen Feb 01, 2032 Novo
Fiasp US8324157 Preparation comprising insulin, nicotinamide and an amino acid Jun 25, 2030 Novo
Fiasp Flextouch US8324157 Preparation comprising insulin, nicotinamide and an amino acid Jun 25, 2030 Novo
Fiasp Flextouch US9687611 Injection device with torsion spring and rotatable display Feb 27, 2027 Novo
Fiasp Flextouch US7686786 Dial-down mechanism for wind-up pen Aug 03, 2026 Novo
Fiasp Flextouch USRE46363 Dial-down mechanism for wind-up pen Aug 03, 2026 Novo
Fiasp Flextouch US10220155 Syringe device with a dose limiting mechanism and an additional safety mechanism Jul 17, 2026 Novo
Fiasp Flextouch US8920383 Dose mechanism for an injection device for limiting a dose setting corresponding to the amount of medicament left Jul 17, 2026 Novo
Fiasp Flextouch US9775953 Dose mechanism for an injection device for limiting a dose setting corresponding to the amount of medicament left Jul 17, 2026 Novo
Fiasp Flextouch US10357616 Injection device with an end of dose feedback mechanism Jan 20, 2026 Novo
Fiasp Flextouch US10376652 Automatic injection device with a top release mechanism Jan 20, 2026 Novo
Fiasp Flextouch US9108002 Automatic injection device with a top release mechanism Jan 20, 2026 Novo
Fiasp Flextouch US9457154 Injection device with an end of dose feedback mechanism Jan 20, 2026 Novo
Fiasp Flextouch US9616180 Automatic injection device with a top release mechanism Jan 20, 2026 Novo
Fiasp Flextouch US9861757 Injection device with an end of dose feedback mechanism Jan 20, 2026 Novo
Fiasp Flextouch US8684969 Injection device with torsion spring and rotatable display Oct 20, 2025 Novo
Fiasp Flextouch US7762994 Needle mounting system and a method for mounting a needle assembly May 23, 2024

(Expired)

Novo
Fiasp Flextouch US8579869 Needle mounting system and a method for mounting a needle assembly Jun 30, 2023

(Expired)

Novo
Fiasp Flextouch US6899699 Automatic injection device with reset feature Jan 02, 2022

(Expired)

Novo
Fiasp Flextouch US8672898 Automatic injection device with reset feature Jan 02, 2022

(Expired)

Novo
Fiasp Flextouch US9486588 Automatic injection device with reset feature Jan 02, 2022

(Expired)

Novo



Insulin Aspart's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Insulin Aspart News

Huisheng Pharm Introduces Self-Developed IDegAsp from China, Aiming to Become a Leader in Diabetes Medication

12 Aug, 2024

See More